The U.S. Food and Drug Administration (FDA) has put healthcare providers on notice about Medline Inc. (NASDAQ:MDLN) convenience kits that include recalled antiseptic applicators made by Becton, Dickinson and Company (NYSE:BDX).

The regulatory warning follows Medline's corrective actions to address kit components affected by an ongoing medical product recall.

What Customers Need to Do

Medline sent out communication letters on June 12 and June 20, telling affected customers to immediately inspect and quarantine existing stock. Healthcare facilities are required to apply the provided over-labels onto affected kits, which state that ChloraPrep components must be removed and disposed of before clinical use.

The rest of the surgical convenience kits, which include instruments and pharmaceutical supplies for surgical procedures, can still be used safely by medical personnel.

Distributors that resold or transferred affected products are instructed to notify secondary recipients right away.

The FDA continues to review data on this high-risk device issue while advising ongoing safety monitoring for healthcare facilities.

Packaging Defects and Contamination Risks

The alert stems from a BD recall involving lot 4032183 of ChloraPrep Clear 1 mL Single Sterile and lot 4073005 of FREPP Clear 1.5 mL applicators.

Packaging wrinkles in the paper lidding compromised sterile seals, exposing patients to potential microbial contamination.

Additionally, environmental factors enabled fungal growth of Aspergillus penicillioides in impacted lots shipped between March 2024 and June 2024.

Fungal contamination can cause systemic infections, sepsis, catheter removals, and prolonged antifungal therapy. Uncomplicated exposures require no follow-up, though exposed patients showing symptoms need prompt evaluation.

Current Incident Reports

As of August 3, Medline has documented zero severe injuries or deaths tied to the kit issues. BD similarly reported no adverse event notices related to the recalled applicators.

MDLN Price Action: Medline shares were up 0.61% at $35.71 at the time of publication on Thursday, according to market data.